Credit rating agency, CRISIL has reaffirmed AA/ stable rating to Ipca Laboratories’ long term bank facilities. The rating agency has also reaffirmed AA/ stable rating to the company’s Rs 20.00 crore Non Convertible Debentures (NCDs) and 50.00 crore Non Convertible Debentures (NCDs) .Total bank long facilities Rs 1182.50 crore
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
